|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 26, 2018 ) The "Global Gene Panel Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global gene panel market with detailed market segmentation by product & services, technique, application, design, end-user and geography. The global gene panel market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The gene panel market is anticipated to grow with a significant rate in the coming years, owing to factors such as increasing prevalence of genetic diseases. In addition, cancer is the key factor for the growth of the Gene panel testing market. Moreover, growing technological advancements such as next generation sequencing (NGS) system, and the need for efficient prenatal diagnosis are significant factors that also fuel the growth of gene panel market in the coming years. On other hand the government initiatives in population sequencing are anticipated to offer more growth opportunities for the players operating in the global gene panel market.
Get Sample PDF of Advanced Information Brochure@ http://bit.ly/2J4FlHn
The global gene panel market is segmented on the basis of product & services, technique, application, design, and end-user. The gene panel market is segmented into testing services and test kits, by product & services. On the basis of the technique, the gene panel market is bifurcated into hybridization-based approach and amplicon-based approach. Based on application, the gene panel market is classified as cancer risk assessment, diagnosis of congenital disorders, pharmacogenetics, and other applications.
Leading Market Players:
1. Illumina, Inc.
2. Agilent Technologies
3. Eurofins Scientific
4. F. Hoffmann-La Roche Ltd
5. Novogene Corporation.
6. Personalis Inc.
7. ArcherDX, Inc.
8. QIAGEN
9. Integrated DNA Technologies, Inc.
10. BGI
The segment of cancer risk assessment is further classified into high-penetrance gene panels, syndrome-specific gene panels, high and moderate-penetrance gene panels and comprehensive cancer risk panels. On the design basis, the gene panel market is categorized into customized gene panels and predesigned gene panels. Based on end users, the gene panel market is classified as hospitals & diagnostic laboratories, research & academic institutes and pharmaceutical & biotechnology companies.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global gene panel market based on product & services, technique, application, design, and end-user. It also provides market size and forecast till 2025 for overall gene panel market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting gene panel market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key gene panel manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Illumina, Inc., Agilent Technologies, Eurofins Scientific, F. Hoffmann-La Roche Ltd, Novogene Corporation., Personalis Inc., ArcherDX, Inc., QIAGEN, Integrated DNA Technologies, Inc., BGI among others.
Check Discount for this Report @ http://bit.ly/2J6Gkqm
The Insight Partners
Sameer Joshi
+1-646-491-9876
sam@theinsightpartners.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
